chromatography

Danaher is financing the deal with $3 billion from an equity offering, cash on hand, and proceeds from an issuance of debt and/or new credit facilities.

The firm's diagnostics and genomics group saw a 13 percent year-over-year revenue increase in the first quarter.

The firms will combine Thermo Fisher's mass spec systems with Evosep's liquid chromatography to develop high-throughput clinical proteomic methods.

Bio-Rad tallied net sales of $551.5 million compared to $500.1 million in Q1 2017, driven by growth in both its Life Science and Clinical Diagnostics businesses.

Phenomenex, a privately held manufacturer of consumables for the separation sciences, will operate as a standalone business and will retain its brand. 

Researchers created a method to identify individual humans using proteins found in hair, correlating single amino acid polymorphisms to non-synonymous SNPs.

Researchers tracked one individual's brain imaging patterns, physical features, blood metabolomics, gene expression, and more.

The firms will share instrument control drivers for chromatographic equipment and expertise to integrate their respective hardware and software.